Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0674
Source ID: NCT00048438
Associated Drug: Paricalcitol
Title: Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Renal Insufficiency, Chronic
Interventions: DRUG: paricalcitol
Outcome Measures: Primary: The efficacy endpoint is achievement of two consecutive > or = 30% decreases from baseline iPTH levels. |
Sponsor/Collaborators: Sponsor: Abbott
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE3
Enrollment: 68
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Start Date: 2002-02
Completion Date:
Results First Posted:
Last Update Posted: 2006-08-15
Locations: UCI Medical Center, Orange, California, 92868, United States|Western Nephrology, Thornton, Colorado, 80260, United States|Outcomes Research International, Inc., Hudson, Florida, 34667, United States|Nephrology Association of South Miami, Miami, Florida, 33173, United States|Tampa Bay Nephrology Associates, Tampa, Florida, 33603, United States|Northwestern University Medical School, Chicago, Illinois, 60611, United States|University of Missouri Health Sciences Center, Columbia, Missouri, 65212, United States|Arms, Dodge, Robinson, Wilber and Crouch, Kansas City, Missouri, 64111, United States|Washington University School of Medicine, St. Louis, Missouri, 63110, United States|NEA Research, Las Vegas, Nevada, 89102, United States|North Shore University Hospital, Great Neck, New York, 11021, United States|Mount Sinai School of Medicine, New York, New York, 10029, United States|Wake Nephrology Associates, PA, Raleigh, North Carolina, 27609, United States|Kidney and Hypertension Center, Cincinnati, Ohio, 45220, United States|Dorn VA Hospital, Columbia, South Carolina, 29209, United States|Dallas Nephrology Associates, Dallas, Texas, 75235, United States|The Vancouver Clinic, Inc., P.S., Vancouver, Washington, 98644, United States|Jagiellonian University, Cracow, Poland
URL: https://clinicaltrials.gov/show/NCT00048438

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress